Title |
Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors
|
---|---|
Published in |
BMC Cancer, February 2013
|
DOI | 10.1186/1471-2407-13-68 |
Pubmed ID | |
Authors |
Atsushi Nambu, Hiroshi Onishi, Shinichi Aoki, Licht Tominaga, Kengo Kuriyama, Masayuki Araya, Ryoh Saito, Yoshiyasu Maehata, Takafumi Komiyama, Kan Marino, Tsuyota Koshiishi, Eiichi Sawada, Tsutomu Araki |
Abstract |
As stereotactic body radiotherapy (SBRT) is a highly dose-dense radiotherapy, adverse events of neighboring normal tissues are a major concern. This study thus aimed to clarify the frequency and degree of clinical symptoms in patients with rib fractures after SBRT for primary lung cancer and to reveal risk factors for rib fracture. Appropriate α/β ratios for discriminating between fracture and non-fracture groups were also investigated. |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 44% |
South Africa | 1 | 11% |
Unknown | 4 | 44% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 44% |
Scientists | 3 | 33% |
Practitioners (doctors, other healthcare professionals) | 2 | 22% |
Mendeley readers
The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 1% |
United Kingdom | 1 | 1% |
Unknown | 68 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 12 | 17% |
Student > Ph. D. Student | 9 | 13% |
Student > Master | 9 | 13% |
Other | 8 | 11% |
Student > Bachelor | 8 | 11% |
Other | 11 | 16% |
Unknown | 13 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 32 | 46% |
Engineering | 5 | 7% |
Physics and Astronomy | 4 | 6% |
Biochemistry, Genetics and Molecular Biology | 3 | 4% |
Agricultural and Biological Sciences | 2 | 3% |
Other | 7 | 10% |
Unknown | 17 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 June 2017.
All research outputs
#5,691,086
of 22,696,971 outputs
Outputs from BMC Cancer
#1,394
of 8,253 outputs
Outputs of similar age
#61,421
of 282,966 outputs
Outputs of similar age from BMC Cancer
#20
of 99 outputs
Altmetric has tracked 22,696,971 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 8,253 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,966 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 99 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.